Last updated on June 2018

UCB Cimzia Pregnancy Follow-up Study

Brief description of study

The purpose of this observational follow-up study is to collect data systematically on pregnancies and offspring of women who become pregnant while participating in a Certolizumab Pegol (CZP) study or whose pregnancies have otherwise been reported to UCB due to potential CZP exposure during pregnancy.

Clinical Study Identifier: NCT02775656

Contact Investigators or Research Sites near you

Start Over

UCB Cares

Up0019 001
Wilmington, NC United States